Stay updated on Risankizumab in PsA Patients: Clinical Trial
Sign up to get notified when there's something new on the Risankizumab in PsA Patients: Clinical Trial page.

Latest updates to the Risankizumab in PsA Patients: Clinical Trial page
- Check7 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check14 days agoChange DetectedThe Publications section received minor wording updates: added clarifications that publications are provided voluntarily and may come from PubMed, and updated the revision from v3.2.0 to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check21 days agoChange DetectedThe page removed a government funding status notice, a generic operational message unrelated to the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check28 days agoNo Change Detected
- Check36 days agoChange DetectedNo additions or deletions were detected between the two screenshots; the Study Details page content and layout appear unchanged.SummaryDifference0.1%

- Check64 days agoChange DetectedSummary of changes: added a government operating-status notice and a new 196-week clinical trial publication citation, and updated the software version from v3.1.0 to v3.2.0; the prior version tag v3.1.0 was removed.SummaryDifference2%

- Check72 days agoChange DetectedThe page updates to Revision: v3.1.0 and removes several drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) from the content.SummaryDifference0.1%

Stay in the know with updates to Risankizumab in PsA Patients: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Risankizumab in PsA Patients: Clinical Trial page.